These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 3313422

  • 21. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
    Darius H, Kopp H, Mulfinger A, Spielberger M, Todt M, Schuster CJ, Meyer J.
    Prog Clin Biol Res; 1989; 301():417-21. PubMed ID: 2508112
    [No Abstract] [Full Text] [Related]

  • 22. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V, Roncaglioni MC, Donati MB, de Gaetano G.
    Thromb Haemost; 1983 Apr 28; 49(2):81-3. PubMed ID: 6346573
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction?
    Knudsen F, Kristensen SD, Nielsen AH, Ring T, Stoffersen E.
    Clin Nephrol; 1985 Feb 28; 23(2):107. PubMed ID: 3886225
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prostacyclin and heparin during haemodialysis: comparative effects.
    Camici M, Evangelisti L.
    Life Support Syst; 1986 Feb 28; 4(3):205-9. PubMed ID: 3537544
    [Abstract] [Full Text] [Related]

  • 31. Prostaglandins and the hemodialysis patient.
    Leslie BR.
    Int J Artif Organs; 1983 May 28; 6(3):105-6. PubMed ID: 6347909
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Paradoxical behaviour of antithrombin III during hemodialysis and its prevention with prostacyclin.
    Turney JH, Fewell M, Williams LC, Dodd N, Weston MJ.
    Clin Nephrol; 1982 Jan 28; 17(1):31-5. PubMed ID: 7035043
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
    Marmo E, Somma A, Ottavo R, Vairo G, Spaziante G, DiMezza F, Paone G.
    J Med; 1981 Jan 28; 12(2-3):97-108. PubMed ID: 7024451
    [No Abstract] [Full Text] [Related]

  • 37. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP, Shebuski RJ, Aiken JW.
    J Pharmacol Exp Ther; 1980 Feb 28; 212(2):246-52. PubMed ID: 6985960
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.